Trexquant Investment LP Cara Therapeutics, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $54,679 - $137,203	11,182 New	11,182 $54,000
Q2 2022 Aug 11, 2022	SELL	$7.45 - $13.84 $278,175 - $516,771	-37,339 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $371,149 - $472,338	37,339 New	37,339 $454,000
Q4 2020 Feb 11, 2021	SELL	$12.72 - $16.16 $192,580 - $244,662	-15,140 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$12.34 - $17.92 $186,827 - $271,308	15,140 New	15,140 $193,000
Q2 2020 Aug 07, 2020	SELL	$12.39 - $17.33 $193,482 - $270,625	-15,616 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$9.12 - $17.78 $142,417 - $277,652	15,616 New	15,616 $206,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.